Third-quarter earnings were ahead of Street expectations, driven mostly by robust growth in the drug division.
GE, American Express, CSX, and Goldman Sachs are also set to report this week. Plus, industrial production and housing starts.
The undervalued pharmaceutical giant is cutting costs and has a strong pipeline, says Damien Conover .
New cancer treatments show promise for patients and investors.
As the ultimate impact of Obamacare comes into focus, the sector’s winners and losers are becoming more apparent.
Obamacare will benefit some sectors more than others, but poor economy and pricing pressures are the biggest challenges most health-care firms must face.
Things look grim, but investors who can bear it could benefit.
Berkshire's portfolio can give some guidance to weary investors.